All News
Avidin has completed Competitiveness and Excellence Co-operations (VKE) successfully
Avidin successfully completed a project entitled Multiparametric immunophenotypic study to characterize diabetes patients, of Competitiveness and Excellence Co-operations (VKE)
Avidin succesfully completed project of EUREKA Innovation Award
Avidin succesfully completed project of EUREKA Innovation Award (E!12655 MITOME)
Avidin can detected new Delta variant
Avidin has detected new Delta variant in Hungary
Novel test for measuring B-cell immunity
Avidin has now developed a method for measuring B-cell immunity.
Avidin combats Alzheimer’s disease with powerful clinical candidate Q134R
Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology.
T-cell immunity test against SARS-CoV2 by Avidin
Avidin has developed a novel blood based diagnostic test that measures acquired T-cell immunity against the SARS-CoV2 coronavirus, following infection or immunization. Avidin is the first private company to offer such a test in Hungary.
Newly accredited M3 authorization level
Avidin’s Budapest site (Berlini u 47-49) was accredited as M3 authorization level of microbiological diagnostics laboratory.
